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Accepted 28 August 2019Biotechnology is an evolving research field that covers a broad range of topics. Here we aimed to evaluate the latest
research literature, to identify prominent research themes, major contributors in terms of institutions, countries/re-
gions, and journals. The Web of Science Core Collection online database was searched to retrieve biotechnology arti-
cles published since 2017. In total, 12,351 publications were identified and analyzed. Over 8500 institutions
contributed to these biotechnology publications, with the top 5 most productive ones scattered over France, China,
the United States of America, Spain, and Brazil. Over 140 countries/regions contributed to the biotechnology research
literature, led by the United States of America, China, Germany, Brazil, and India. Journal of Bioscience and Bioengineer-
ing was the most productive journal in terms of number of publications. Metabolic engineering was among the most
prevalent biotechnology study themes, and Escherichia coli and Saccharomyces cerevisiae were frequently used in bio-
technology investigations, including the biosynthesis of useful biomolecules, such as myo-inositol (vitamin B8),mono-
terpenes, adipic acid, astaxanthin, and ethanol. Nanoparticles and nanotechnology were identified too as emerging
biotechnology research themes of great significance. Biotechnology continues to evolve andwill remain amajor driver







Biotechnology research covers a broad range of topics. As defined in the
scopes of the journals Current Research in Biotechnology and Current Opinion
in Biotechnology, major themes of biotechnology research include genetic
and molecular engineering; tissue, cell, and pathway engineering; plant
and animal biotechnology; food biotechnology; energy biotechnology; en-
vironmental biotechnology; analytical biotechnology; systems biology;
nanobiotechnology; chemical biotechnology; medicinal and pharmaceuti-
cal biotechnology. The term biotechnology is attributed to be coined by
the agricultural economist-cum-engineer Karl Erkey from Hungary, exactly
100 years ago. Karl Erkey defined biotechnology as, translated into English,
“all the lines of work by which products are produced from raw materials
with the aid of living organisms” (Amarakoon et al., 2017; Bud, 1994).
The Organization for Economic Co-operation and Development (OECD),
an intergovernmental economic organization with 36 member countries,
refined the definition of biotechnology as “application of scientific and en-
gineering principles to the processing of materials by biological agents to
provide goods and services; new biotechnology involves the use of cellular
and molecular processes to solve problems or make products” (Amarakoon
et al., 2017). Starting in the mid-1980s, biotechnology became a very pop-
ular word in the title of research publications, appearing in papers
concerning business, industry, biomedicine, chemical engineering, agricul-
tural sciences, and even social sciences (Kennedy, 1991). In short, biotech-
nology signifies a new biological approach to a wide range of industries.
Biotechnology was suggested to have mainly 4 sectors, white, red,
green, and blue, which represent industrial, pharmaceutical/medical,
food and agriculture, and environment/marine, respectively (Barcelos
et al., 2018). Twowell-known examples of daily applications of biotechnol-
ogy are the production of the multifunctional citric acid by fermentation
with the aid of Aspergillus niger, and, to a lesser extent, Yarrowia lipolytica
(Karaffa and Kubicek, 2003), as well as the use of Y. lipolytica as a model
for bio-oil production (Beopoulos et al., 2009); and the production of
non-nutritive sweeteners, steviol glucosides and mogrosides, from plants
Stevia rebaudiana and Siraitia grosvenorii, respectively (Pawar et al., 2013).
Meanwhile, genetically-modified (GM) foods represent another
biotechnology-derived aspect that significantly affects our everyday life.
A survey conducted in 2002 reported that the majority of consumers
were negative about GM foods, as their moral and ethical concerns about
GM food consumption outweighed the benefits of better taste and lower35price (Magnusson and Hursti, 2002). In 2015, however, GM crops were al-
ready grown on 180 million hectares of land in 28 countries, equivalent to
10% of total arable land worldwide (Taheri et al., 2017). While GM crops
and GM foods will likely continue to flourish with the advancements in bio-
technology, consumer surveys repeatedly indicate inferior consumer accep-
tance reflected in the lower willingness of purchasers to pay for GM foods
than for non-GM foods (Colson and Rousu, 2013).
Red (medical and pharmaceutical) biotechnology has witnessed impor-
tant recent developments and makes strong impact on human health and
disease therapies. Biotechnology has been a frontline field driving both
uncovering of molecular mechanisms of diseases and identification of
new molecular biomarkers and drug targets (e.g., through the use of
engineered biological models with knock-out, knock-down, or overexpres-
sion of relevant proteins), as well as the identification and subsequent phar-
maceutical development of therapeutics (e.g., many antibiotics, other small-
molecule natural product-derived drugs, and recombinant proteins such as
antibodies and hormones) (Gartland et al., 2013).
Bibliometric analyses of biotechnology literature were so far occasion-
ally published to reflect on the evolution of the field or evaluate the contri-
butions and performances of specific countries. For a detailed list of such
studies published until 2001, readers are referred to Table 1 of the work
published in 2002 by Dalpé (Dalpé, 2002). In this latest addition of biotech-
nology literature analysis, we aimed to unveil the latest trends (since 2017)
in biotechnology research. By analyzing the research literature, we identi-
fied the latest popular research themes, major contributors in terms of insti-
tutions, countries/regions, and journals.2. Materials and methods
2.1. Literature search
InMay 2019, a searchwas conducted through theWebof Science (WoS)
Core Collection electronic database (Clarivate Analytics, Philadelphia,
USA) to identify the latest biotechnology publications. The following search
string was used: TOPIC= (“biotech*”). This search strategy yielded publi-
cations that mentioned the words biotech, biotechnology or their deriva-
tives in the title, abstract, or keywords. In order to focus on contemporary
biotechnology research trends, only articles published between 2017 and
2019 were included.
Table 1








French National Center for Scientific Research (CNRS) 236 (1.9%) 3.6
Chinese Academy of Sciences 216 (1.7%) 3.6
University of California system 214 (1.7%) 4.6
Spanish National Research Council (CSIC) 204 (1.7%) 4.4
University of São Paulo 177 (1.4%) 2.6
Country/region
The United States of America 2208 (17.9%) 3.9
China 1559 (12.6%) 3.3
Germany 1056 (8.6%) 3.6
Brazil 862 (7.0%) 2.0
India 756 (6.1%) 2.8
Journal
Journal of Bioscience and Bioengineering 500 (4.0%) 1.8
Biotechnology and Bioengineering 224 (1.8%) 6.5
Applied Microbiology and Biotechnology 208 (1.7%) 2.9
Biotechnology Progress 181 (1.5%) 2.3
Scientific Reports 166 (1.3%) 3.1
A.W.K. Yeung et al. Current Research in Biotechnology 1 (2019) 34–402.2. Data extraction and analysis
The bibliographic data of the included biotechnology publications were
extracted, which included publication year, authorship, institutions, coun-
tries/regions of the institutions, journal title, WoS journal category, publi-
cation type, language, publication count, and citation count. The
“Analyze” and “Create Citation Report” functions of the WoS platform
were used for the initial analyses. The “full records and cited references”
were exported and loaded into VOSviewer software (version 1.6.11,
www.vosviewer.com) for further bibliometric analyses.
The VOSviewer software analyzes the terms used in titles and abstracts
of the included publications, relates them to publication and citation data,
and illustrates the results by a term map (van Eck and Waltman, 2009;
Yeung et al., 2017; Yeung et al., 2019a). In a term map, the bubble size re-
flects how frequently a term is mentioned in the included publications
(multiple mentioning in one publication counts as one only). The bubble
color, on the other hand, reflects how frequently a publication mentioning
the term is cited on average (citations per publication, CPP). Lastly, the dis-
tance between two bubbles reflects how frequently two terms are men-
tioned in the same publications. Only words that appear in at least 1% (n
= 124) of the manuscripts are analyzed and visualized. The frequencies
of author keywords and keywords added by WoS are also analyzed by
VOSviewer.3. Results and discussion
3.1. General landscape
The annual numbers of biotechnology publications indexed in WoS for
years 2017–2019 (until May) were 5294, 5345, and 1712 respectively,
summing up to a total of 12,351. These articles were predominantly pub-
lished in English (n = 12,045; 97.5%). Original articles (n = 9043;
73.2%) were more prevalent than review papers (n = 2308; 18.7%), pro-
ceedings papers (n=569; 4.6%), editorial materials (327; 2.6%), or meet-
ing abstracts (n = 126; 1.0%) (Fig. 1). Among the top 25 most productive
authors, 18 had a Chinese name, with the top 2 being “Wang Y” and
“Zhang Y”. It is a known issue of WoS that some publications are recorded
with initialized author names, which may confound the authors' publica-
tion counts by merging multiple authors into one, especially for initialized

























Fig. 1. Publication count of d
363.2. Institutions and countries/regions
Over 8500 institutions contributed to these biotechnology publications.
The top 5 most productive institutions were scattered over France, China,
the United States of America, Spain, and Brazil (Table 1). These were
followed by the Russian Academy of Sciences, Helmholtz Association of
German Research Centres, French National Institute for Agricultural Re-
search (INRA), the United States of America Department of Energy, and
the Technical University of Denmark. Over 140 countries/regions contrib-
uted to biotechnology research, with the top 5 most productive ones
being the United States of America, China, Germany, Brazil, and India. To-
gether, these distributions highlight the latest (since 2017) worldwide re-
search interest in biotechnology. These findings are also consistent with
the report that countries like China, India, and Brazil are among the emerg-
ing science influencers that are currently publishing nearly 20 times more
papers than they were in the early-1980s (Adams, 2013). A closer look
into the most cited Brazilian publications revealed bioremediation as a
common theme. Notable examples included an investigation of the gut mi-
crobiota as a potential tool to degrade insecticides (de Almeida et al.,








The publication count and citation per publication of the top 20 most productive
journal categories.
Journal category Publication count Citation per publication
Biotechnology applied microbiology 3599 3.1
Biochemistry molecular biology 1297 3.4
Food science technology 1077 2.1
Microbiology 924 3.2
Chemistry multidisciplinary 817 4.2
Multidisciplinary sciences 665 3.2
Plant sciences 645 2.7
Biochemical research methods 551 2.8
Engineering chemical 470 2.0
Environmental sciences 452 3.3
Pharmacology pharmacy 391 2.3
Materials science multidisciplinary 326 3.3
Chemistry physical 293 3.6
Chemistry applied 274 3.1
Genetics heredity 272 3.1
Nanoscience nanotechnology 267 4.5
Energy fuels 262 5.0
Polymer science 258 4.4
Engineering environmental 237 3.0
Management 223 1.5
A.W.K. Yeung et al. Current Research in Biotechnology 1 (2019) 34–40contaminant chromium (Vendruscolo et al., 2017), and the use of
microalgae and cyanobacteria to biofix carbon dioxide emitted from coal
power plants (Duarte et al., 2017). Among the most cited Indian publica-
tions, the oxidase laccase was one of the common themes. Notable exam-
ples included a study that optimized the production of laccase from a
fungus under solid state fermentation (Chenthamarakshan et al., 2017),
and a demonstration of biodegradation of toxic textile dyes mediated by
laccase produced by bacteria (Kuppusamy et al., 2017).Fig. 2. Termmap of biotechnology publications. There were 411 terms that appeared in
extracted fromWeb of Science. The bubble size reflects how frequently a termwasmentio
one only). The bubble color reflects how frequently a publication mentioning the term w
terms were mentioned in the same publications.
373.3. Journals and journal categories
Journal of Bioscience and Bioengineering stood out as the most productive
journal, having contributed to 4.0% of all publications,more than double of
the contribution by the 2nd journal (Biotechnology and Bioengineering; con-
tributing 1.8%). This is different from other recently analyzed sets of liter-
ature in which no single journal clearly outperformed the others, e.g., in the
research fields of dietary natural products (Yeung et al., 2018a), curcumin
(Yeung et al., 2019b), resveratrol (Yeung et al., 2019c), and neuropharma-
cology (Yeung et al., 2018b). While the reasons for this observation are not
entirely clear, it is apparent that Journal of Bioscience and Bioengineering
(2018 journal impact factor of 2.03; publishing original full-length research
papers, reviews, and Letters to the Editor) might currently represent a plat-
form preferred by authors for publishing biotech-related articles (factors
such as broadness of scope, diversity of article types, and acceptance rate
can certainly be of importance in the context of this observation). In
terms of journal category, we could also show that the dominating category
was Biotechnology applied microbiology, having three-fold more contribu-
tions compared to the 2nd category. On the other hand, by examining the
top 20 categories, one could appreciate the diversity of biotechnology re-
search,which overlappedwith the areas of biology, chemistry, engineering,
plant sciences, microbiology, pharmacology, genetics, nanoscience, and
management (Table 2). This wide spectrum is illustrative for the highly in-
terdisciplinary nature of biotechnology-linked research that expands be-
yond the life sciences to cover scientific works from fields such as
engineering or management. In management journals, for example, rele-
vant publications often analyzed biotechnology cases to investigate how
knowledge advancements and maturation could be adopted as product in-
novations (Capaldo et al., 2017; Moeen and Agarwal, 2017). Along the
same lines, biotech startup companies have become popular in recent
years, propelled by collaborations between the industry and academia via>1% (n=124) of the 12,351 publications published in 2017–2019 (until May) and
ned in the included publications (multiplementioning in one publication counted as
as cited on average. The distance between two bubbles reflects how frequently two
Table 4















Biotechnology 810 (6.6%) 2.3 306 351 134
Metabolic engineering 184 (1.5%) 5.2 68 90 22
Synthetic biology 171 (1.4%) 3.9 50 87 28
Fermentation 131 (1.1%) 2.6 57 52 19
Microalgae 112 (0.9%) 2.9 23 65 23
Escherichia coli 98 (0.8%) 2.8 39 43 14
Cyanobacteria 93 (0.8%) 3.1 34 45 13
Bioremediation 91 (0.7%) 3.8 30 42 13
Saccharomyces cerevisiae 91 (0.7%) 3.0 44 38 7
Biocatalysis 90 (0.7%) 4.8 39 35 14
Nanoparticles 81 (0.7%) 3.6 27 32 17
Immobilization 80 (0.6%) 4.8 30 36 10
Innovation 80 (0.6%) 1.5 30 41 9
Gene expression 76 (0.6%) 2.4 33 35 6
Yeast 76 (0.6%) 2.7 31 26 16
Genome editing 75 (0.6%) 3.1 21 36 15
Bacteria 72 (0.6%) 2.7 18 37 14
Biomass 71 (0.6%) 2.5 31 32 8
Enzymes 70 (0.6%) 2.9 32 26 9
Nanotechnology 70 (0.6%) 3.1 32 26 11
Genetic engineering 65 (0.5%) 2.0 19 34 12
Biodegradation 60 (0.5%) 3.8 13 32 10
Lipase 59 (0.5%) 2.5 6 22 10
Protein engineering 59 (0.5%) 2.4 20 24 14
Industrial
biotechnology
56 (0.5%) 2.6 16 31 7
A.W.K. Yeung et al. Current Research in Biotechnology 1 (2019) 34–40various models of consultancy, contract research, and public-private part-
nerships (Pronk et al., 2015). Hence, we expect an increasing contribution
of biotechnology-linked research to be published by management journals
in the near future. Along the same line, the highly interdisciplinary nature
of biotechnology-linked research is also well reflected in the first four arti-
cles accepted for publication in Current Research in Biotechnology, which are
coming from entirely different research spheres, in particular representing
an expert opinion on safety of genome edited crops (Lassoued et al.,
2019), research describing the development of whole-cell bacterial electro-
chemical urea sensor (Cabrera et al., 2019), study on the potential of die-
tary supplementation with black pepper to improve blood lipid levels,
and the development of copper oxide-loaded polyacrylonitrile nanofiber
membranes for antimicrobial breath mask applications (Kim et al., 2019).
3.4. Term map
The term map revealed that many of the publications investigated the
production (n = 3345; CPP = 3.0) or synthesis (n = 917; CPP = 3.6) of
valuable biomolecules, e.g., via bacteria (n = 1328; CPP = 3.0) (Fig. 2).
Biotechnology was applied to study/modify genes (n = 1831; CPP =
2.6) and enzymes (n= 1875; CPP = 3.2), and to create optimized or syn-
thetic metabolic networks and pathways for the production of biomole-
cules. Some of the more cited terms included biosensor (n = 170; CPP =
5.9), microbe (n = 252; CPP = 5.1); biofuel (n = 236; CPP = 4.8), poly-
mer (n = 335; CPP = 4.8), metabolic engineering (n = 238; CPP =
4.8), and nanotechnology (n = 194; CPP = 4.4). The 25 most frequently
mentioned terms are mostly words with more general meaning (e.g., pro-
duction, application, analysis) and are listed in Table 3.
3.5. Keywords
Metabolic engineering was the second most prevalent author keyword,
ranking in second place immediately after biotechnology, and the related
term synthetic biology came in third place. Both author keywords and key-
words added by WoS indicated that Escherichia coli and Saccharomyces
cerevisiae were the most frequently used organisms in biotechnology inves-
tigations, including biosynthesis of valuable biomolecules (Tables 4 and 5).
E. coli is a highly popular model organism used in a range of biotechnology
applications, such as in metabolic engineering, where it can be modified to
produce valuable compounds via synthetic metabolic networks (Erb et al.,Table 3
The top 25 recurring terms from titles and abstracts.
Term Publication count (% of total) Citation per publication
Study 4509 (36.5%) 2.5
Biotechnology 3680 (29.8%) 3.2
Production 3345 (27.1%) 3.0
Application 2977 (24.1%) 3.8
Analysis 2907 (23.5%) 2.3
Activity 2647 (21.4%) 2.8
Process 2635 (21.3%) 2.8
Development 2577 (20.9%) 3.3
System 2462 (19.9%) 3.5
Use 2194 (17.8%) 3.0
Effect 2124 (17.2%) 2.5
Approach 2120 (17.2%) 3.4
Protein 2057 (16.7%) 3.0
Cell 2012 (16.3%) 3.1
Condition 2011 (16.3%) 2.6
Enzyme 1875 (15.2%) 3.2
Gene 1831 (14.8%) 2.6
Research 1758 (14.2%) 3.1
Review 1678 (13.6%) 5.4
Product 1656 (13.4%) 3.1
Property 1625 (13.2%) 3.5
Strain 1624 (13.1%) 2.6
Technology 1617 (13.1%) 3.4
Strategy 1592 (12.9%) 3.5
Concentration 1525 (12.3%) 2.4
382017), such as myo-inositol (inositol) (You et al., 2017) and monoterpenes
(Korman et al., 2017); and in genetic engineering,where the recently devel-
oped CRISPR and its associated genome-editing techniques yielded many
follow-up studies that apply to diverse species (Burstein et al., 2017;
Pawluk et al., 2018; Komor et al., 2017). Similarly, engineered
S. cerevisiae is, for example, deployed to produce adipic acid, a usefulmono-
mer in nylon synthesis (Kruyer and Peralta-Yahya, 2017); astaxanthin, a
keto-carotenoid which is a food colorant and potent antioxidant (Zhou
et al., 2019); and also biofuels, such as ethanol, converted fromxylose in ag-
ricultural residues and energy crops (Kwak and Jin, 2017; Jansen et al.,
2017). Similarly, biotechnology applications can also be used for scaled-Table 5
The top 25 recurring keywords added by Web of Science (Keywords Plus).
Keyword Publication count (% of total) Citation per publication
Escherichia coli 735 (6.0%) 3.9
Expression 716 (5.8%) 2.3
Biotechnology 597 (4.8%) 1.8
Identification 517 (4.2%) 2.1
Growth 497 (4.0%) 2.2
Purification 490 (4.0%) 1.9
Protein 360 (2.9%) 2.2
Saccharomyces cerevisiae 340 (2.8%) 4.1
In vitro 326 (2.6%) 3.6
Biosynthesis 312 (2.5%) 2.9
Gene-expression 312 (2.5%) 3.6
Gene 300 (2.4%) 2.6
Bacteria 267 (2.2%) 2.7
Optimization 266 (2.2%) 2.0
Fermentation 265 (2.1%) 2.5
Diversity 256 (2.1%) 2.1
Proteins 255 (2.1%) 2.3
System 234 (1.9%) 2.9
Performance 225 (1.8%) 1.7
Cells 224 (1.8%) 2.6
Nanoparticles 224 (1.8%) 3.3
Enzymes 216 (1.7%) 2.8
Evolution 214 (1.7%) 3.1
Degradation 212 (1.7%) 2.5
Acid 202 (1.6%) 2.9
Fig. 3. Structures of selected natural products with biotechnological relevance.
A.W.K. Yeung et al. Current Research in Biotechnology 1 (2019) 34–40up production of natural products that become successful drugs (Atanasov
et al., 2015) or have other biomedical applications (Brahmi et al., 2018;
Cătană et al., 2018; Eid et al., 2017; Ververidis et al., 2007). Biocatalysis
was another popular topic, which relates to optimization of existing en-
zymes, including their immobilization for improving their stability and
multiple usages, to fit into predefined parameters for producing pharma-
ceuticals and commodity chemicals (Sheldon and Woodley, 2017). Bioca-
talysis is also a central theme in environmental and medical
bioremediation research (Karigar and Rao, 2011; Mathieu et al., 2009).
The chemical structures of selected chemicals with biotechnological rele-
vance are presented in Fig. 3.
Both author keywords and keywords added byWoS indicated nanopar-
ticles and nanotechnology to be trending research themes in the recent
(since 2017) biotechnology literature. For instance, some relevant recent
works from this area focused on the synthesis of nanofibers that could be
applied in tissue engineering, drug delivery systems, and wound dressings
(Haider et al., 2018). Important application-area of nanotechnology is
also the use of engineered nanoparticle-mediated delivery of genes and
biotherapeutic agents (Singh et al., 2017). Metal nanoparticles were also
studied as additives to improve the combustion performance and stability
of diesel engines (Saxena et al., 2017).
4. Conclusion
We conducted a bibliometric analysis of the biotechnology research lit-
erature since 2017. Over 12,000 publications were identified and analyzed.
Over 8500 institutions contributed to biotechnology publications during
this period. The top 5 most productive institutions were scattered over
France, China, the United States of America, Spain, and Brazil. Over 140
countries/regions contributed to biotechnology research, with the top 5
most productive ones being the United States of America, China,
Germany, Brazil, and India. Journal of Bioscience and Bioengineering was
the most productive journal in terms of numbers of publications, and
E. coli and S. cerevisiaewere frequently involved in the biotechnology inves-
tigations. The traditionally important theme of metabolic engineering was
also among the most important biotechnology research topics of the ana-
lyzed time period (2017–2019), and nanoparticles/nanotechnology are
contemporary trending biotechnology research themes. It is expected that
genetic and metabolic engineering will continue to thrive to further im-
prove the efficacy of biosynthesis of useful chemicals and bioremediation
of environmental pollutants. When the 25 most frequent keywords for
2017, 2018, and 2019 were examined separately, we found that purifica-
tion, genomics, fungi, laccase, and biofilm were on the list in 2017, but39were replaced by protein engineering, thermostability, biofuels, innovative
biotechnologies, and drug delivery in 2019. Biotechnology research as a
whole will continue to make strong impact on the environment, medicine,
agriculture, food, and other diverse industrial areas. With more advanced
technology on protein engineering, biofuels, and drug delivery, it is ex-
pected that biotechnology will particularly create a greener environment,
and benefit human health.Funding
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